Bardey, D.; Bommier, A.; Jullien, B. - In: Journal of Health Economics 29 (2010) 2, pp. 303-316
Our paper is a first attempt to evaluate the long run impact of reference pricing on pharmaceutical innovation, health and expenditures. The model is based on a dynamic game involving three types of agents: pharmaceutical firms, consumers and a regulatory entity. Pharmaceutical firms choose the...